rs80338899
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000561421.6(FAH):c.786G>A(p.Trp262Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000561421.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAH | NM_000137.4 | c.786G>A | p.Trp262Ter | stop_gained | 9/14 | ENST00000561421.6 | NP_000128.1 | |
FAH | NM_001374377.1 | c.786G>A | p.Trp262Ter | stop_gained | 10/15 | NP_001361306.1 | ||
FAH | NM_001374380.1 | c.786G>A | p.Trp262Ter | stop_gained | 10/15 | NP_001361309.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAH | ENST00000561421.6 | c.786G>A | p.Trp262Ter | stop_gained | 9/14 | 1 | NM_000137.4 | ENSP00000453347 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000795 AC: 20AN: 251482Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135914
GnomAD4 exome AF: 0.0000581 AC: 85AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.0000578 AC XY: 42AN XY: 727244
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74362
ClinVar
Submissions by phenotype
Tyrosinemia type I Pathogenic:5Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 12, 2019 | NM_000137.2(FAH):c.786G>A(W262*) is classified as pathogenic in the context of type I tyrosinemia. Sources cited for classification include the following: PMID 8723698, 8162054, 15465000, 7942842, 15638932 and 8829657. Classification of NM_000137.2(FAH):c.786G>A(W262*) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening. - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 01, 2020 | - - |
not provided, no classification provided | literature only | GeneReviews | - | Finnish-specific pathogenic variant resulting from founder effect or genetic drift [Angileri et al 2015]. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1996 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 29, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change creates a premature translational stop signal (p.Trp262*) in the FAH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAH are known to be pathogenic (PMID: 9101289, 9633815). This variant is present in population databases (rs80338899, gnomAD 0.07%). This premature translational stop signal has been observed in individuals with tyrosinemia type I in Scandinavia (PMID: 7942842, 8162054, 8829657). ClinVar contains an entry for this variant (Variation ID: 11873). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at